Visalytics
Visalytics
approved EB-2 (NIW)

Doctor/ Cardiologist

Medicine · China · 2025-05-01

Processing Time
321 days
Decision Date
2025-05-01
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue her research into the molecular mechanisms underlying cardiovascular disease, specifically focusing on the gut microbiota's role in hypertension and the STING pathway in aortic dissection. Her work involves developing innovative gene therapies for heart regeneration and identifying novel molecular targets to improve patient outcomes. The endeavor aims to advance therapeutic interventions for complex cardiovascular conditions within U.S. medical research settings.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses cardiovascular disease, a major health concern, contributing to U.S. healthcare innovation and disease prevention.

2 Well-positioned to Advance the Endeavor Met

The petitioner's extensive publication record, high citation count, and history of NIH funding demonstrate her ability to lead successful medical research.

3 Waiver Benefit to the US Met

On balance, the petitioner's contributions to heart disease treatment and regenerative medicine outweigh the need for a labor certification.

Why This Petition Was Approved

The petition was approved based on the petitioner's 24 peer-reviewed journal articles and 4 scientific abstracts which garnered 2,266 citations, placing her in the top 1% of cited authors in her field. Evidence included 19 completed peer reviews for top-tier journals and research funding from the NIH and the National Natural Science Foundation. The case successfully satisfied all three Dhanasar prongs by demonstrating the national importance of cardiovascular research and the petitioner's exceptional positioning in the field.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Grants
Judging Experience
Original Contributions
Government Alignment

Similar Cases

Postdoctoral Researcher

Healthcare · Iran

WeGreened EB-2 (NIW) approved
USA 141 days 2025-04-03
The petitioner proposes to investigate the molecular mechanisms underlying cardiovascular diseases to translate these insights into new pharmaceutical therapies. The work involves conducting research within U.S. academic environments to develop treatment paths that minimize invasive procedures and improve cardiovascular outcomes.
View Case

Researcher

Biotechnology · Brazil

WeGreened EB-2 (NIW) approved
126 days 2022-03-29
The petitioner proposes to continue her research on cardiovascular disease to facilitate the development of novel treatments and improve existing therapeutic approaches. Her work specifically focuses on elucidating the pathophysiology of cardiovascular diseases to advance next-generation medical interventions.
View Case

Postdoctoral Researcher

Biotechnology

WeGreened EB-2 (NIW) approved
Midwestern US 478 days 2025-04-01
The petitioner proposes to continue translational research focused on uncovering disease mechanisms through advanced genetic and animal model studies. This work specifically targets the understanding and treatment of complex inherited conditions, including inherited mutations and cardiac diseases, within a U.S. medical research institution.
View Case

Doctor

Healthcare · Nigeria

WeGreened EB-2 (NIW) approved
United Kingdom 6 days 2023-10-03
The petitioner proposes to perform cardiovascular disease research by leveraging AI machine learning models, data analysis, bioinformatics, and epidemiology. The work focuses on reducing patient mortality, enhancing the accuracy of predicting cardiovascular disease occurrences, and alleviating the financial burden of healthcare spending.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Healthcare cases More cases from China

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-05-01.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 321 days
Criteria Met 3 / 3
Evidence Types 7

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in China All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist